Insulins were negatively associated with breast (n = 15; RR = 0.90; 95% CI = 0.82–0.98) and prostate cancer risks (n = 7; RR = 0.74; 95% CI = 0.56–0.98). This evidence concerns the gene INS and prostate cancer.